Regenerative Medicines: Development Slowed By Lack of Standardization, Regulatory And Manufacturing Challenges
Executive Summary
A Government Accountability Office report identifies 10 policy options aimed at speeding development and boosting the use of regenerative therapies, but breaks little new ground, highlighting the continuing difficulties in the space.